Matsumoto Yosuke, Nomura Kenichi, Matsumoto Sawako, Ueda Kyoji, Nakao Mitsushige, Nishida Kazuhiro, Sakabe Hideaki, Yokota Shohei, Horiike Shigeo, Nakamine Hirokazu, Nakamura Shigeo, Taniwaki Masafumi
Department of Medicine, Division of Hematology and Oncology, Kyoto Prefectural University of Medicine, Kawaramachi Hirokoji, Kamigyo-ku, Kyoto 602-0841, Japan.
Cancer Genet Cytogenet. 2004 Apr 1;150(1):22-6. doi: 10.1016/j.cancergencyto.2003.08.008.
We studied the incidence of t(14;18)(q32;q21) in 54 patients with follicular lymphoma (FL) by dual-color fluorescence in situ hybridization on paraffin-embedded tissue sections (tissue-FISH) using probes for BCL2 and immunoglobulin heavy chain (IGH) genes. The t(14;18) was detected in 28 (56%) of 50 patients, who were successfully analyzed. On the other hand, BCL2 protein expression was detected in 45 (83%) of 54 patients evaluated by immunohistochemical staining. There was a discrepancy between t(14;18) and BCL2 expression. The absence of t(14;18) was associated with disease-free survival (P=0.02). There was no statistical difference, however, in overall survival and failure-free survival between the t(14;18)-positive and -negative groups. Tissue-FISH should be of great value to detect t(14;18) in FL because this method enabled us to demonstrate specifically t(14;18)-positive individual cells in neoplastic follicles on paraffin-embedded tissue sections. Furthermore, tissue-FISH can be applied to small specimens obtained from endoscopic biopsy or specimens obtained more than 10 years ago. We validated the usefulness of tissue-FISH as a diagnostic procedure and retrospective meta-analysis for malignant lymphoma.
我们通过双色荧光原位杂交技术,利用针对BCL2和免疫球蛋白重链(IGH)基因的探针,对54例滤泡性淋巴瘤(FL)患者石蜡包埋组织切片进行检测(组织荧光原位杂交),研究了t(14;18)(q32;q21)的发生率。在成功分析的50例患者中,有28例(56%)检测到t(14;18)。另一方面,通过免疫组织化学染色评估,54例患者中有45例(83%)检测到BCL2蛋白表达。t(14;18)与BCL2表达之间存在差异。未检测到t(14;18)与无病生存期相关(P = 0.02)。然而,t(14;18)阳性和阴性组在总生存期和无失败生存期方面没有统计学差异。组织荧光原位杂交在检测FL中的t(14;18)方面具有重要价值,因为该方法使我们能够在石蜡包埋组织切片的肿瘤滤泡中特异性地显示t(14;18)阳性的单个细胞。此外,组织荧光原位杂交可应用于内镜活检获取的小标本或10多年前获取的标本。我们验证了组织荧光原位杂交作为恶性淋巴瘤诊断程序和回顾性荟萃分析的有用性。